Risk factors

Gilead Sciences (GILD) risk factors

Item 1A of every Gilead Sciences, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open GILD in Gloom →
Gilead Sciences' chart, financials and news, free in your browser.Open GILD in Gloom →
  • FY2025 10-K risk factors
    23 risks2 new1 dropped10 reworded

    Gilead adds execution risk around its planned $32 billion U.S. manufacturing and R&D investment through 2030.

    Filed Feb 24, 2026
  • FY2024 10-K risk factors
    22 risks

    HIV product revenue concentration makes maintaining market share and launching replacement therapies central business risks.

    Filed Feb 28, 2025